Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab.

Authors	Larissa Valor-Méndez, Georg Schett, Bernhard Manger
Journal	Clinical and experimental rheumatology (Clin Exp Rheumatol) Vol. 40 Issue 4 Pg. 854-855 (05 2022) ISSN: 0392-856X [Print] Italy
PMID	34796852 (Publication Type: Letter)
Chemical References	Antibodies, Monoclonal, Humanized belimumab
Topics	Antibodies, Monoclonal, Humanized (therapeutic use) Humans Lupus Erythematosus, Systemic (complications, diagnosis, drug therapy) Urticaria (diagnosis, drug therapy, etiology) Vasculitis (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!